The intestinal microbiota of the Elderly

Gastrointestinal Microbiology

Volumn , Issue , 2006, Pages 75-92

  He, Fang ^a  

^a Yokohama Kanagawa   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84861144259     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (73)

1. Saunier K, Dore J. Gastrointestinal tract and the elderly: functional foods, gut microflora and healthy ageing. Dig Liver Dis 2002; 34:19-24.
2. Kalache A. Active ageing makes the difference. Bull. WHO 1999; 77:299.
3. Schneeman BO. Gastrointestinal physiology and function. Br J Nutr 2002; 88:159-163.
4. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1997; 31:107-133.
5. Tissier H. Recherches sur la flora intestinal des nourrisson. Theses Paris 1900; 1-253.
6. Benno Y, Sawada K, Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol 1984; 28:975-986.
7. Yuhara T, Isojima S, Tsuchiya F, Mitsuoka T. On the intestinal flora of bottle-fed infant. Bifidobact Microflora 1983; 2:33-39.
8. Mitsuoka T. A Color Atlas of Anaerobic Bacteria. Tokyo: Sobunsya, 1980.
9. Mitsuoka T. Intestinal flora and aging. Nutr Rev 1992; 50:438-446.
10. Mitsuoka T. Significance of dietary modulation of intestinal flora and intestinal environment. Biosci Microflora 2000; 19:15-25.
11. Russell RM. Changes in gastrointestinal function attributed to aging. Am J Clin Nutr 1992; 55:1203S-1207S.
12. Gill HS, Darragh AJ, Cross ML. Optimizing immunity and gut function in the healthy. J Nutr Health Aging 2001; 5:80-91.
13. Holt PR. Gastrointestinal disease in the elderly. Curr Opin Clin Nutr Metab Care 2003; 6:41-48.
14. Haenel H. Über die Mikroökologie alter Menschen. Zentralbl Bakteriol Hyg I Orgi 1963; 188:219-230.
15. Haenel H. Gesetzmäbigkeiten in der Zusammensetzung der fakalen Mikroflora. Eubiose und Dysbiose der menschlichen Darmbesiedlung. Ernährungsforschung 1965; 10:289-301.
16. Jantea F, Nicolae D, Bad-Oprisescu D, Voina P. Beitrag zur Darmmikroflora bei Menschen im Alter von 45-100 Jahren. Ernährungsforschung 1965; 10:352-362.
17. Gorbach SL, Nahas L, Lerner P, Weinstein L. Studies of intestinal microflora 1. Effects of diet, age, and periodic sampling on number of fecal microrganisms in man. Gastroenterology 1967; 53:845-855.
18. Mitsuoka T, Hayagawa K. Die Faecalflora bei Menschen I: Mitteilung: Die Zusanmmensetzung der Faecalflora der verschiedenen Altersgruppen. Zbl Bakt Hyg I Abt Org 1972; 223:333-342.
19. Mitsuoka T, Hayagawa K, Kimura N. Die Faekalflora bei Menschen II: Mitteilung: Die Zusammensetzung der Bifidobakterienflora der verschiedenen Altersgruppen. Zbl Bakt Hyg I Abt Org 1973; 226:469-478.
20. Mitsuoka T, Ohno K, Benno Y, Suzuki K, Namba K. Die Faekalflora bei Menschen IV. Mitteilung: Vergleich des neu entwickelten Verfahrens mit dem bisherigen üblichen Verfahren zur Darmfloraanalyse. Zbl Bakt Hyg I Abt Org 1976; 224:219-233.
21. Benno Y. Mitsuoka Development of intestinal microflora in human and animal. Bifdobact Microflora 1986; 5:13-25.
22. Blaut M, Collins MD, Welling GW, Dore J, van Loo J, de Vos W. Molecular biological methods for studying that gut microbiota: the EU human gut flora project. Br J Nutr 2002; 87:S203-S211.
23. Hopkins MJ, Sharp R, Macfarlane GT. Age and disease related changes in intestinal bacterial population assessed by cell culture, 16S rRNA abundance, and community cellular fatty acid profiles. Gut 2001; 48:198-205.
24. Hopkins MJ, Macfarlane GT. Changes in predominant bacterial population in human faces with age and with Clostridium difficile infection. J Med Microbiol 2002;448-454.
25. Hopkins MJ, Sharp R, Macfarlane GT. Variation in human intestinal microbiota with age. Dig Liver Dis 2002; 34:512-518.
26. Mitsuoka T. Intestinal Bacteria and Health. Japan: Harcourt Brace Jovanovich, 1978.
27. Björkstén B, Naaber P, Sepp E, Mikelsaar M. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy 1999; 29:342-346.
28. Kuvaeva IB, Orlova NG, Veselova OL, Kuznezova GG, Borovik TE. Microecology of the gastrointestinal tract and the immuneological status under food allergy. Nahrung 1984; 28:689-693.
29. Orla-Jensen S. La classification des bactéria lactiques. Lait 1924; 4:468-474.
30. Reuter G. Vergleichende Untersuchungen über die Bifidus-Flora im Sauglings- und Erwachsenenstuhl. Zbl Bakt I Orig 1963; 191:486-507.
31. Reuter G. Designation of type strains for Bifidobacterium-species. Int J Syst Bact 1971; 21:273-275.
32. Mitsuoka T. Vergleichende Untersuchungen über die Bifidobakterien aus dem Verdauungstrakt von Menschen und Tieren. Zbl Bakt I Orig 1969; 210:52-64.
33. Mitsuoka T. Taxonomy and ecology of bifidobacteria. Bifidobacteria Microflora 1984; 3:11-28.
34. Lauer E, Kandler O. DNA-DNA homology, murein type and enzyme patterns in the type strains of the genus Bifidobacterium. Syst Appl Microbiol 1983; 4:42-62.
35. Scardovi V. Genus Bifidobacterium. Orla-Jensen 1924. In: Sneath et al., eds. Bergey’s Manual of Systematic Bacteriology: Vol. 2 Section 15, Philadephia: The Williams & Wilkins Company, 1986; 1418-1434.
36. Moore WE, Holdeman LV. Human fecal flora: the normal flora of 20 Japanese-Hawaiians. Appl Microbiol 1974; 27:961-979.
37. Finegold SM. Normal human intestinal flora. Ann 1st Super Sanita 1986;731-737.
38. He F, Ouwehand AC, Isolauri E, Hosoda M, Benno Y, Salminen S. Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. Curr Microbiol 2001; 43:351-354.
39. Satokari RM, Vaughan EE, Akkermans ADL, Saarela M, de Vos WM. Bifidobacterial diversity in human feces detected by genus-speciic PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol 2001; 67:504-513.
40. Mullie C, Odou MF, Singer E, Romond MB, Izard D. Multiplex PCR using 16 S rRNA genetargeted primers for the identifyication of bifidobacteria from human origin. FEMS Microbiol Lett 2003; 222:129-136.
41. Matsuki T, Watanabe K, Fujimoto J, et al. Development of 16 S rRNA-gene-targeted groupspecies primers fro the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 2002; 68:5445-5451.
42. Isolauri E, Sütas Y, Kankaanpää P, Arvilommi H, Salminen S. Probiotics: effects on immunity. Am J Clin Nutr 2001; 73:444S-450S.
43. Ouwehand AC, Tuomola EM, Lee YK, Salminen S. Microbial interactions to intestinal mucosal models. Methods Enzymol 2001; 337:200-212.
44. Kohler H, McCormick BA, Walker WA. Bacterial-enterocyte crosstalk: cellular mechanisms in health and disease. J Pediatr Gastroenterol Nutr 2003 Feb; 36:175-185.
45. Salminen S, Laine M, von Wright A, Vuopio-Varkila J, Korhonen T, Mattila-Sandholm T. Development of selection criteria for probiotic strains to acess their potential I n functional food. A Nordic and European approach. Biosci Microflora 1996; 2:23-28.
46. Ouwehand AC, Isolauri E, Kirjavanen PV, Salminen SJ. Adhesion of four Bifidobacterium strains to human intestinal mucus from subjects in different age groups. FEMS Microbiol Lett 1999; 172:61-64.
47. He F, Ouwehand AC, Hashimoto H, Isolauri E, Benno Y, Salminen S. Adhesion of Bifidobacterium spp. to human intestinal mucus. Microbiol Immunol 2001; 45:259-262.
48. Laine R, Salminen S, Benno Y, Ouwehand AC. Performance of bifidobacteria in oat-based media. Int J Food Microbiol 2003; 83:105-109.
49. Pawelec G. Immunosenescence: impact in the young as well as the old? Mech Ageing Dev 1999; 108:1-7.
50. Mishto M, Santoro A, Bellavista E, Bonafe M, Monti D, Franceschi C. Immunoproteasomes and immunosenescence. Ageing Res Rev 2003; 2:419-423.
51. Ginaldi L, Martinis MD, D’ Ostilio A, Marini L, Loreto MF, Quaglino D. Immunological changes in the elderly. Ageing Clin Exp Res 1999; 11:281-286.
52. Lesourd B, Mazari L. Nutrition and immunity in the elderly. Proc Nutr Soc 1999; 58:685-695.
53. Castle SC. Clinical relevance of age-related immune dysfunction. Clin Infect Dis 2000; 31:578-585.
54. Effros RB. Ageing and immune system. Novartis Found Symp 2001; 235:130-145.
55. Grubeck-Loebenstein B. Changes in the ageing immune system. Biologicals 1997; 25:205-208.
56. Peakman M, Vergani D. Basic and Clinical Immunology. Hong Kong: Churchill Livingstone, 1997:1-388.
57. Fujimoto T, Duda RB, Szilvasi A, Chen X, Mai M, O’Donnell MA. Streptococcal preparation OK-432 is a potent inducer of IL-12 and T helper cell 1 dominant state. J Immunol 1997; 158:5619-5629.
58. Haller D, Blum S, Bode C, Hammes WP, Schiffrin EJ. Activation of human peripheral blood mononuclear cells by nonpathogenic bacteria in vitro: evidence of NK cells as primary targets. Infect Immun 2000; 68:752-759.
59. Hessle C, Honson LA, Wold AE. Lactobacilli from human gastrointestinal mucosa are strong stimulators of IL-12 production. Clin Exp Immunol 1999; 116:276-282.
60. Hessle C, Andersson B, Wold AE. Gram-positive bacteria are potent inducers of monocytic interleukin-12 (IL-12) while gram- negative bacteria preferentially stimulate IL-10 production. Infect Immun 2000; 68:3581-3586.
61. Karlsson H, Hessle C, Rudin A. Innate immune responses of human neonatal cells to bacteria from normal gastrointestinal flora. Infect Immun 2002; 70:6688-6696.
62. He F, Morita H, Ouwehand AC, et al. Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. Microbiol Immunol 2002; 46:781-785.
63. He F, Isolauri E, Morita H, et al. Bifidobacteria isolated from allergic and healthy infants: differences in taxonomy, mucus adhesion and immune modulation effects. Microecol Ther 2002; 29:103-108.
64. Morita H, He F, Fuse T, et al. Adhesion of lactic acid bacteria to Caco-2 cells and their effects on cytokine secretion. Microbiol Immunnol 2002; 46:293-297.
65. Fuller R. Probiotics in man and animals. J Appl Bacteriol 1989; 66:365-378.
66. Salminen S, Ouwehand A, Benno Y, Lee YK. Probiotics: how should they be defined? Trends Food Sci Technol 1999; 10:107-110.
67. Gill HS. Stimulation of the immune system by lactic culture. Int Dairy J 1998; 8:535-544.
68. Borchers AT, Keen CL, Gershwin ME. The influence of yogurt/Lactobacillus on the innate and acquired immune response. Clin Rev Allergy Immunol 2002; 22:207-230.
69. Matsuzaki T, Yamazaki R, Hashimoto S, Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J Dairy Sci 1998; 81:48-53.
70. Aso Y, Akaza H, Kotake T, Tsukamoto T, Imai K, Naito S. BLP Study Group. Preventive effects of a Lactobacillus casei preparation on the recurrence of superficial cancer in a doubleblind trial. Eur Urol 1995; 27:104-109.
71. Cross ML, Gill HS. Can Immunoregulatory lactic acid bacteria be used as dietary supplements to limit allergies? Int Arch Allergy Immunol 2001; 125:112-119.
72. Gill HS, Rutherfurd KJ, Cross ML. Dietary probiotics supplementation enhances natural killer cell activity in the elderly: an investigation of age-related immunological changes. J Clin Immunol 2001; 21:264-271.
73. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr 2001; 74:833-839.